[Video] Evolution of orphan drug access in Latin America
By NextLevel Life Sciences - April 01, 2016

Leading up to NextLevel Pharma’s Market Access in Latin America Leaders Forum, we would like to share with you a presentation from the previous event to give you an insight into the topics the 2016 event will build upon.

The presentation we would like to share is titled: “Evolution of orphan drug access in Latin America: review of policy environment & recent successes” and is presented by Sandeep Duttagupta, Principal & Vice President at CBPartners (USA).

Register now & join market access leaders in Sao Paolo at the Market Access in Latin America Leaders Forum 2016! This two-day event will allow all participants the ability to learn about the current market access approaches which are required for each market in order for them to have greater certainty that their products will be able to deliver real value in the correct terms (cost-effectiveness/ cost-utility/ cost-benefit/ cost-minimization). Participants will hear from a range of Payers (Public & Private), HTAs and academics who are all shaping the market access landscape in Latin America and will hear first-hand how the requirements for market access are evolving and what will need to be done to maximize their chances of a commercially successful product launch.


SANDEEP DUTTAGUPTA, Principal & Vice President, CBPartners, USA

Dr. Duttagupta has spent his entire career focused on pricing, access, and value demonstration issues within the emerging markets. With the firm, Dr. Duttagupta focuses on providing strategic guidance to clients dealing with all emerging markets commercialisation issues, with a focus on pricing and market access.

Prior to joining CBPartners, Dr. Duttagupta spent two decades with Pfizer, where he most recently ran the pricing and market access functions within the emerging markets. In this role, he led the development of the company's strategic emerging markets pricing framework, devised multiple innovative access initiatives involving local banks and NGOs, developed multiple second-brand strategies to minimise IRP risk and maintain market share, and implemented partnerships with Ministries of Health around the world.

Dr. Duttagupta leads and advises on all emerging markets engagements, including those within the Pricing & Market Access, Value Demonstration, Global Policy Advisory, Commercial Planning, and Portfolio Optimisation practices.

For more information regarding NextLevel Pharma’s Market Access in Latin America Leaders Forum click here.